Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
39,878,866
-
Share change
-
+5,189,541
-
Total reported value
-
$317,779,054
-
Price per share
-
$7.97
-
Number of holders
-
65
-
Value change
-
+$44,804,928
-
Number of buys
-
42
-
Number of sells
-
15
Institutional Holders of POINT BIOPHARMA GLOBAL INC - COM (PNT) as of Q1 2022
As of 31 Mar 2022,
POINT BIOPHARMA GLOBAL INC - COM (PNT) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,878,866 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, VANGUARD GROUP INC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, Fairmount Funds Management LLC, GREAT POINT PARTNERS LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.